Test Code CKMB Creatine Kinase-MB
Additional Codes
Cerner |
NextGen |
CKMB2 |
CKMB2 |
Alternate Name(s)
CK-MB
Creatine Phosphokinase-MB
CPK-MB
Useful For
Creatine kinase (CK) is a key enzyme of energy metabolism in muscle, catalyzing the reversible physphorylation of creatine. This dimeric enzyme has two active subunits, M and B, which associate to form three isoenzymes, CK-MM, CK-MB, and CK-BB. CK-MM is found predominantly in skeletal muscle and CK-BB in brain. CK-MB is found predominantly in cardiac muscle accounting for approximately 10-40% of myocardial CK.
The low concentration of CK-MB in normal serum and non-cardiac tissues is the basis of its widely accepted use as a diagnostic indicator of myocardial injury. Damage to the myocardium results in a transient release of CK-MB into the circulation. This increase in CK-MB reaches a peak in 12 to 24 hours, then returns to normal within 48 to 72 hours. This characteristic temporal pattern is diagnostic for AMI. Approximately 98% of patients with AMI exhibit elevated serum CK-MB while only 3% of non-AMI patients exhibit abnormal CK-MB.
Methodology
Chemiluminescent Immunometric
Patient Preparation
None
Collection Instructions
Standard phlebotomy practices.
Specimen Requirements
Container |
|
||||||||||||
Stability |
|
||||||||||||
Rejection Criteria |
Gross Hemolysis Turbid Specimens |
Result Reporting and Reference Values
Reported in ng/mL
No reference range studies for patients <18 years old
Age |
Reference Range |
18Y-150Y |
0.00-3.38 |
Reflex Testing
None
Limitations
- Ortho reports a bias with the following:
- Cefoxitin, Dextran 40, Gamma Globulin can cause a negative bias
- Ortho reports no significant effect with the following:
- Bilirubin up to 40 mg/dL
- Hemoglobin up to 501 mg/dL